Suning Chen
Overview
Explore the profile of Suning Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
313
Citations
2256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu J, Xue S, Wang Y, He X, Hu X, Miao M, et al.
Blood
. 2025 Feb;
PMID: 40009498
Venetoclax combined with hypomethylating agents is approved for frontline therapy in older/unfit acute myeloid leukemia (AML) patients. However, prospective data on this low intensity therapy in treatment-naive younger AML patients...
2.
Zhang X, Han Y, Qiu H, Han M, Sun A, Xue S, et al.
Clin Cancer Res
. 2025 Feb;
:OF1-OF8.
PMID: 40008901
Purpose: To assess the efficacy and safety of an induction regimen composed of idarubicin, cytarabine, and cladribine (IAC) in patients with de novo acute myeloid leukemia (AML). Patients And Methods:...
3.
Lu J, Yang G, Zhang Q, Wang M, Wang L, Chen L, et al.
Front Oncol
. 2025 Feb;
15:1495182.
PMID: 40008001
The gene ETV6 has been confirmed to be a genetic susceptibility gene for thrombocytopenia and leukemia. Here, we report a long-chain noncoding RNA AC010198.2 as a novel fusion partner of...
4.
Lu J, Zhu Y, Qiu H, Wang Y, Zhou X, Dai H, et al.
Discov Oncol
. 2025 Feb;
16(1):223.
PMID: 39984805
Background: Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia (Ph-negative BCP-ALL) accounts for a significant portion of adult cases. Blinatumomab, a bispecific T-cell engager, has shown efficacy in relapsed or refractory BCP-ALL,...
5.
Feng Z, Hu X, Li W, Xu T, Xu Y, Xue S, et al.
Haematologica
. 2025 Feb;
PMID: 39973368
Not available.
6.
Bao X, Chen Y, Chang J, Du J, Yang C, Wu Y, et al.
BMC Cancer
. 2025 Feb;
25(1):273.
PMID: 39955536
Background: Dysregulation or abnormality of the programmed cell death (PCD) pathway is closely related to the occurrence and development of many tumors, including acute myeloid leukemia (AML). Studying the abnormal...
7.
Wang X, Zhang K, Wang L, Xu J, Wang Y, Chen S, et al.
Curr Opin Hematol
. 2025 Feb;
PMID: 39937685
Purpose Of Review: The lack of optimal treatments for haematological disorders has led to the need for prediction models for diagnosis, therapeutic decision-making and life planning. In this review, the...
8.
Shen J, Shan M, Chu M, Cai Y, Rui J, Chen S, et al.
Blood Cancer J
. 2025 Feb;
15(1):17.
PMID: 39934109
No abstract available.
9.
Chu Y, Zhou B, Gao R, Miao M, Qiu H, Tang X, et al.
Blood Cancer J
. 2025 Feb;
15(1):11.
PMID: 39910042
No abstract available.
10.
A Rare Case of Triple-Hit Ultra-High-Risk Multiple Myeloma Harboring t(4;14), t(14;20), and Gain(1q)
Lu J, Wang Q, Wang J, Zeng Z, Shi X, Liu D, et al.
Int J Lab Hematol
. 2025 Feb;
PMID: 39891400
No abstract available.